These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37962020)

  • 1. Loss of SETD2 aggravates colorectal cancer progression caused by SMAD4 deletion through the RAS/ERK signalling pathway.
    Ma C; Liu M; Feng W; Rao H; Zhang W; Liu C; Xu Y; Wang Z; Teng Y; Yang X; Ni L; Xu J; Gao WQ; Lu B; Li L
    Clin Transl Med; 2023 Nov; 13(11):e1475. PubMed ID: 37962020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SETD2 deficiency promotes renal fibrosis through the TGF-β/Smad signalling pathway in the absence of VHL.
    Liu C; Ni L; Li X; Rao H; Feng W; Zhu Y; Zhang W; Ma C; Xu Y; Gui L; Wang Z; Aji R; Xu J; Gao WQ; Li L
    Clin Transl Med; 2023 Nov; 13(11):e1468. PubMed ID: 37933774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The histone methyltransferase SETD2 modulates oxidative stress to attenuate experimental colitis.
    Liu M; Rao H; Liu J; Li X; Feng W; Gui L; Tang H; Xu J; Gao WQ; Li L
    Redox Biol; 2021 Jul; 43():102004. PubMed ID: 34020310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SETD2 epidermal deficiency promotes cutaneous wound healing via activation of AKT/mTOR Signalling.
    Li X; Liu C; Zhu Y; Rao H; Liu M; Gui L; Feng W; Tang H; Xu J; Gao WQ; Li L
    Cell Prolif; 2021 Jun; 54(6):e13045. PubMed ID: 33949020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial Smad4 Deletion Up-Regulates Inflammation and Promotes Inflammation-Associated Cancer.
    Means AL; Freeman TJ; Zhu J; Woodbury LG; Marincola-Smith P; Wu C; Meyer AR; Weaver CJ; Padmanabhan C; An H; Zi J; Wessinger BC; Chaturvedi R; Brown TD; Deane NG; Coffey RJ; Wilson KT; Smith JJ; Sawyers CL; Goldenring JR; Novitskiy SV; Washington MK; Shi C; Beauchamp RD
    Cell Mol Gastroenterol Hepatol; 2018; 6(3):257-276. PubMed ID: 30109253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFR in Tumor-Associated Myeloid Cells Promotes Development of Colorectal Cancer in Mice and Associates With Outcomes of Patients.
    Srivatsa S; Paul MC; Cardone C; Holcmann M; Amberg N; Pathria P; Diamanti MA; Linder M; Timelthaler G; Dienes HP; Kenner L; Wrba F; Prager GW; Rose-John S; Eferl R; Liguori G; Botti G; Martinelli E; Greten FR; Ciardiello F; Sibilia M
    Gastroenterology; 2017 Jul; 153(1):178-190.e10. PubMed ID: 28400195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimetastatic role of Smad4 signaling in colorectal cancer.
    Zhang B; Halder SK; Kashikar ND; Cho YJ; Datta A; Gorden DL; Datta PK
    Gastroenterology; 2010 Mar; 138(3):969-80.e1-3. PubMed ID: 19909744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Black Raspberries Suppress Colorectal Cancer by Enhancing Smad4 Expression in Colonic Epithelium and Natural Killer Cells.
    Huang YW; Lin CW; Pan P; Shan T; Echeveste CE; Mo YY; Wang HT; Aldakkak M; Tsai S; Oshima K; Yearsley M; Xiao J; Cao H; Sun C; Du M; Bai W; Yu J; Wang LS
    Front Immunol; 2020; 11():570683. PubMed ID: 33424832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-20a-5p promotes colorectal cancer invasion and metastasis by downregulating Smad4.
    Cheng D; Zhao S; Tang H; Zhang D; Sun H; Yu F; Jiang W; Yue B; Wang J; Zhang M; Yu Y; Liu X; Sun X; Zhou Z; Qin X; Zhang X; Yan D; Wen Y; Peng Z
    Oncotarget; 2016 Jul; 7(29):45199-45213. PubMed ID: 27286257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the ERK pathway reduces liver metastasis of Smad4-inactivated colorectal cancer.
    Ai X; Wu Y; Zhang W; Zhang Z; Jin G; Zhao J; Yu J; Lin Y; Zhang W; Liang H; Datta PK; Zhang M; Zhang B; Chen X
    Cancer Biol Ther; 2013 Nov; 14(11):1059-67. PubMed ID: 24025354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ochratoxin A promotes chronic enteritis and early colorectal cancer progression by targeting Rinck signaling.
    Liu X; Yan C; Chang C; Meng F; Shen W; Wang S; Zhang Y
    Phytomedicine; 2024 Jan; 122():155095. PubMed ID: 37844381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SETD2 loss perturbs the kidney cancer epigenetic landscape to promote metastasis and engenders actionable dependencies on histone chaperone complexes.
    Xie Y; Sahin M; Sinha S; Wang Y; Nargund AM; Lyu Y; Han S; Dong Y; Hsieh JJ; Leslie CS; Cheng EH
    Nat Cancer; 2022 Feb; 3(2):188-202. PubMed ID: 35115713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of microRNA-21-3p suppresses proliferation as well as invasion and induces apoptosis by targeting RNA-binding protein with multiple splicing through Smad4/extra cellular signal-regulated protein kinase signalling pathway in human colorectal cancer HCT116 cells.
    Hou N; Guo Z; Zhao G; Jia G; Luo B; Shen X; Bai Y
    Clin Exp Pharmacol Physiol; 2018 Jul; 45(7):729-741. PubMed ID: 29542167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone methyltransferase SETD2 modulates alternative splicing to inhibit intestinal tumorigenesis.
    Yuan H; Li N; Fu D; Ren J; Hui J; Peng J; Liu Y; Qiu T; Jiang M; Pan Q; Han Y; Wang X; Li Q; Qin J
    J Clin Invest; 2017 Sep; 127(9):3375-3391. PubMed ID: 28825595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smad4-mediated signaling inhibits intestinal neoplasia by inhibiting expression of β-catenin.
    Freeman TJ; Smith JJ; Chen X; Washington MK; Roland JT; Means AL; Eschrich SA; Yeatman TJ; Deane NG; Beauchamp RD
    Gastroenterology; 2012 Mar; 142(3):562-571.e2. PubMed ID: 22115830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of Setd2 promotes Kras-induced acinar-to-ductal metaplasia and epithelia-mesenchymal transition during pancreatic carcinogenesis.
    Niu N; Lu P; Yang Y; He R; Zhang L; Shi J; Wu J; Yang M; Zhang ZG; Wang LW; Gao WQ; Habtezion A; Xiao GG; Sun Y; Li L; Xue J
    Gut; 2020 Apr; 69(4):715-726. PubMed ID: 31300513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SETD2 regulates chromatin accessibility and transcription to suppress lung tumorigenesis.
    Xie Y; Sahin M; Wakamatsu T; Inoue-Yamauchi A; Zhao W; Han S; Nargund AM; Yang S; Lyu Y; Hsieh JJ; Leslie CS; Cheng EH
    JCI Insight; 2023 Feb; 8(4):. PubMed ID: 36810256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and histopathologic characterization of SETD2-mutated colorectal cancer.
    Bushara O; Wester JR; Jacobsen D; Sun L; Weinberg S; Gao J; Jennings LJ; Wang L; Lauberth SM; Yue F; Liao J; Yang GY
    Hum Pathol; 2023 Jan; 131():9-16. PubMed ID: 36502925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smad4 sensitizes colorectal cancer to 5-fluorouracil through cell cycle arrest by inhibiting the PI3K/Akt/CDC2/survivin cascade.
    Zhang B; Leng C; Wu C; Zhang Z; Dou L; Luo X; Zhang B; Chen X
    Oncol Rep; 2016 Mar; 35(3):1807-15. PubMed ID: 26647806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.